Mr. Trent Northcutt reports

AURORA SPINE ANNOUNCES ISSUANCE OF TWO U.S. PATENTS

Aurora Spine Corp. has received two independent United States patents by the U.S. Patent and Trademark Office. The issuance of these patents strengthens the company's intellectual property portfolio and reinforces its long-term innovation strategy across multiple spinal implant platforms.

New issued U.S. patent for the ZIP implant family

The first patent issued was No. 12,478,411 B2, titled Spinal Implant for Motion Preservation or Fusion, representing the 10th issued U.S. patent supporting the ZIP implant family. This patent further expands the protected design space around Aurora Spine's most established and clinically adopted platform.

The patented technology covers a spinal implant architecture designed to support either motion preservation or fusion, depending on clinical application. The design incorporates multiple interacting structural components that distribute load and engage progressively under physiological forces, addressing limitations of traditional rigid implants while maintaining stability and durability.

"The issuance of the tenth patent for the ZIP implant family highlights the strength, longevity and originality of this platform," said Trent J. Northcutt, president and chief executive officer of Aurora Spine. "ZIP has been a foundational technology for our company, and this milestone further reinforces our ability to protect and evolve solutions that address real biomechanical and clinical challenges in spine surgery."

Third patent for bone density scan result-matched orthopedic implants

Aurora Spine also announced the issuance of U.S. patent No. 12,478,481 B2, titled Bone Density Scan Result-Matched Orthopedic Implants and Methods of Use. This patent protects a distinct technology focused on selecting orthopedic implants based on a patient's bone density scan results, such as DEXA measurements.

The patented method establishes a structured, data-driven framework that enables surgeons to:

• Utilize objective bone density data to guide implant selection;
• Match implant characteristics to patient bone quality;
• Apply a standardized approach across varying bone density profiles.

This technology forms the basis of Aurora Spine's DEXA technology platform, which represents the company's third bone-density-matched implant system patent.

"Bone quality is one of the most important variables in spine surgery, yet it has historically been underutilized in implant selection," said Laszlo Garamszegi, chief technology officer and co-founder of Aurora Spine. "This patent establishes a formal, repeatable method for aligning implant selection with patient bone characteristics using objective data."

Strengthening Aurora Spine's innovation strategy

The same-day issuance of these two patents underscores Aurora Spine's continued investment in diverse, non-overlapping innovation pathways. Each patent independently supports future product development, clinical differentiation and long-term shareholder value while reinforcing the company's reputation for meaningful, surgeon-driven innovation.

Both patents are now issued and enforceable in the United States.

About Aurora Spine Corp.

Aurora Spine is an innovative designer and manufacturer of minimally invasive spinal implants and interventional pain management technologies. Headquartered in Carlsbad, Calif., the company's mission is to improve spinal surgery outcomes through simplified, integrated and cost-effective solutions that advance patient care worldwide.

We seek Safe Harbor.